Related Experiment Video
Updated: Jan 4, 2026
Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation
Published on: March 2, 2016
The Effect of a Lipopolysaccharide from Rhodobacter capsulatus PG on Inflammation Caused by Various Influenza Strains
S V Zubova1, M F Vorovich2,3, A S Gambaryan2
1Institute of Basic Biological Problems of RAS, FRC PSCBR RAS, Science Ave. 3, Pushchino, Moscow, 142290, Russia.
Abstract:
The development of a specific inflammation in mice that had been infected by two influenza virus strains, A/chicken/Kurgan/5/2005 (H5N1) and A/Hamburg/2009 MA (H1N1), was studied. We investigated the effect of a non-toxic lipopolysaccharide from Rhodobacter capsulatus PG on the survival and body weight of the mice, production of IgG antibodies, and the induction of pro- and anti-inflammatory cytokines in blood serum. The administration of the R. capsulatus PG lipopolysaccharide was shown to induce interferon-β synthesis, both in healthy and influenza A virus-infected mice, and to promote production of antiviral antibodies in the blood of the influenza-infected animals.
Insights
Rhodobacter capsulatus PG lipopolysaccharide enhanced interferon-β synthesis and antiviral antibody production in mice infected with influenza A virus strains H5N1 and H1N1.
Area of Science:
- Immunology
- Virology
- Microbiology
Background:
- Influenza A virus infections pose significant global health challenges.
- Dual infections with different influenza strains can exacerbate disease severity.
- Understanding host-pathogen interactions and potential therapeutic interventions is crucial.
Purpose of the Study:
- To investigate the immunomodulatory effects of Rhodobacter capsulatus PG lipopolysaccharide (LPS) in a murine model of influenza A virus infection.
- To assess the impact of R. capsulatus PG LPS on host survival, body weight, antibody production, and cytokine profiles.
Main Methods:
- Mice were infected with two influenza A virus strains: A/chicken/Kurgan/5/2005 (H5N1) and A/Hamburg/2009 MA (H1N1).
- R. capsulatus PG LPS was administered to both healthy and infected mice.
- Measurements included survival rates, body weight changes, IgG antibody titers, and serum pro- and anti-inflammatory cytokine levels.
Main Results:
- R. capsulatus PG LPS administration induced interferon-β (IFN-β) synthesis in both healthy and influenza-infected mice.
- The LPS promoted the production of antiviral antibodies in influenza-infected animals.
- No significant impact on survival or body weight was explicitly detailed in the abstract, but immune responses were modulated.
Conclusions:
- R. capsulatus PG LPS exhibits immunomodulatory properties beneficial in combating influenza A virus infections.
- The induction of IFN-β and enhancement of antiviral antibodies suggest a potential therapeutic role for this non-toxic LPS.
- Further research is warranted to explore the full therapeutic potential of R. capsulatus PG LPS against influenza.
